About LARALAB
LARALAB, a healthcare AI company, specializes in developing advanced image-based software and a cloud-based platform, heart.ai, designed to significantly enhance procedural planning and guidance for heart interventions. For physicians, this platform offers a robust tool for analyzing complex medical image data, such as cardiac CT scans, to automatically segment various anatomical structures of the heart. This automation aids in precisely determining optimal puncture sites, selecting suitable catheters, and identifying appropriate implants for individual patients undergoing transcatheter therapies, including Mitral, Tricuspid, and Aortic Valve procedures.
The company’s technology aims to streamline the pre-procedural assessment workflow, providing instant screening results without extensive manual workup. This capability is crucial for improving efficiency in both routine patient care and clinical trials, ultimately leading to more timely and effective treatment decisions. LARALAB has also introduced ‘REC – Rapid Eligibility Check,’ an AI-driven tool for quick patient eligibility assessments, further supporting structural heart teams in identifying viable treatment pathways and optimizing patient selection for interventions.
Focus Areas
Business Intelligence
| Key Investors | EIT Health, Philips HealthWorks, Xpreneurs |
| Partnerships | Columbia University (TTVR-AHI Registry), HDZ Bad Oeynhausen (CESAR-TR Registry), LMU Hospital (Generative AI for Cardiac Treatments), Abbott (TMVR screening collaboration), Philips Global AI start-up program |
| Acquisitions | Acquired by Abbott Laboratories on October 27, 2025 |
| Technology | Proprietary deep learning and cloud technology, cloud-native deployment, web-based medical viewer, AI operating system |
| FDA Clearances | 1 cleared products (estimated) |
What Physicians Need to Know
For physicians, LARALAB's platform offers significant time savings through rapid, AI-driven pre-screening and eligibility checks, allowing focus on viable treatment pathways and eliminating ineligible options quickly. The high-precision, automated CT analysis and comprehensive coverage across all major heart valves enhance diagnostic accuracy and support personalized procedural planning for transcatheter therapies. Regulatory clearances (FDA 510(k) and CE mark) provide confidence in clinical application, while interpretable reports facilitate understanding and communication. The cloud-native deployment ensures accessibility and scalability, making it a valuable tool for optimizing workflows and improving patient outcomes in interventional cardiology.
LARALAB's heart.ai platform is designed for cloud-native deployment, offering a secure and scalable solution for integration within hospital systems, research organizations, and device companies. It is DICOM compliant, ensuring seamless import and processing of medical images. The company's acquisition by Abbott in October 2025 suggests potential for deeper integration with Abbott's existing structural heart portfolio and digital health offerings.
Reviews & Opinions
Videos
News, demos, and interviews about LARALAB.
Videos load interactively. If none appear, search YouTube for LARALAB →
Press & Coverage
Frequently Asked Questions
Investors
Who's funded LARALAB.
Related Companies
Visiopharm is a leading provider of AI-driven precision pathology software, catering to both research and diagnostic applications. For physicians, Visiopharm offers advanced tools that transform pathology through image analysis, aiming to enhance precision and productivity in pathology labs. The company has developed nine diagnostic algorithms cleared under IVDR for EU and UK customers, which provide […]
TSI (Transworld Systems Inc.) is a long-standing company primarily known for its debt collection and business process outsourcing services. While they serve various industries, including healthcare, their core offering is focused on accounts receivable management and collections rather than healthcare-specific AI development. They provide solutions to help healthcare providers manage patient accounts, improve cash flow, […]
TrialX is a healthcare AI company specializing in clinical research and space health informatics. The company develops platforms designed to connect patients with clinical trials and facilitate research data collection. Their offerings include an enterprise patient recruitment platform (iConnect) that provides a clinical trials finder (Dory), study website builders, pre-screeners, referral tracking, and volunteer registries. […]
Thinkitive is a global IT services and solutions company that specializes in digital transformation, enterprise application services, outsourced product development, and a testing center of excellence. For physicians, Thinkitive offers a range of AI-driven healthcare solutions designed to streamline clinical and administrative workflows, enhance patient care, and improve operational efficiency. Their services include custom healthcare […]
Taction Software is a U.S.-based healthcare IT and custom software development company specializing in HIPAA-compliant solutions. They build AI-powered applications for healthcare, ranging from rapid clinical AI prototypes to production-grade systems with EHR integration, ambient documentation, and predictive analytics. The company focuses on transforming healthcare delivery through secure, compliant, and innovative software solutions that aim […]
SUPERWISE offers an enterprise AI governance and operations platform designed to help organizations, including those in healthcare, deploy and manage autonomous AI systems with oversight and control. The platform addresses governance, compliance, and operational challenges associated with AI and machine learning deployments. It features real-time guardrails for AI systems, model observability capabilities, and compliance automation, […]